Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Total Debt/Equity

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Total Debt/Equity History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Total Debt/Equity(x) 0.250.130.460.400.67

What is the latest Total Debt/Equity ratio of GLENMARK PHARMACEUTICALS ?

The latest Total Debt/Equity ratio of GLENMARK PHARMACEUTICALS is 0.25 based on Mar2025 Consolidated results.
Year Total Debt/Equity
Mar20250.25
Mar20240.13
Mar20230.46
Mar20220.40
Mar20210.67

How is Total Debt/Equity of GLENMARK PHARMACEUTICALS Trending?

Years Total Debt/Equity % Change
Mar2025 0.25
92.31
Mar2024 0.13
-71.74
Mar2023 0.46
15.00
Mar2022 0.4
-40.30
Mar2021 0.67 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Total Debt/Equity ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹56,634.7 Cr -1.6% 2.8% 26.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,073.0 Cr -0% -3.2% -5% Stock Analytics
DIVIS LABORATORIES ₹175,657.0 Cr 4% 5.2% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,121.0 Cr 3.6% 7% 22% Stock Analytics
CIPLA ₹118,431.0 Cr -3.5% -1.5% -2.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,944.0 Cr -3.2% -3.3% -10.6% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-1.6%

2.8%

26.6%

SENSEX

-2.6%

-1.3%

7.2%


You may also like the below Video Courses